newsfilter
← Latest News
ACCESS Newswire·

NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements

ZURICH, SWITZERLAND / ACCESSWIRE / October 28, 2024 / NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company focused on the